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Introduction
WNK1 (with-no-K[Lys] kinase-1) was originally identifi  ed as 
an unusual kinase that lacked an invariant catalytic Lys residue 
in subdomain II of the catalytic domain that is crucial for bind-
ing of ATP (Xu et al., 2000). WNK1 is a catalytically active 
kinase, and modeling (Xu et al., 2000), as well as structural 
analysis, of the WNK1 catalytic domain (Min et al., 2004) re-
vealed that a Lys residue in subdomain I substitutes for the 
missing Lys residue in subdomain II. WNK1 is a widely ex-
pressed protein kinase comprising 2,382 residues. It possesses 
a kinase catalytic domain at its N terminus (residues 221–479), 
and apart from three putative coiled-coil domains, the remain-
der of the WNK1 polypeptides possess no obvious structural 
features (Verissimo and Jordan, 2001; Xu et al., 2005). Great 
interest in WNK1 was aroused after the fi  nding that intronic 
  deletions that increased WNK1 expression were observed in 
 humans with an inherited hypertension and hyperkalemia (elevated 
plasma K
+) disorder termed Gordon’s syndrome or pseudohy-
poaldosteronism type II (OMIM 145260; Wilson et al., 2001). 
These fi  ndings indicated that overexpression of WNK1 may 
  result in hypertension and, consistent with this, heterozygous 
WNK1
−/+ mice possess reduced blood pressure (Zambrowicz 
et al., 2003). WNK1-knockout embryos fail to develop, indicat-
ing that WNK1 is also required for normal development. There 
are four isoforms of WNK (WNK1, -2, -3, and -4) in humans 
encoded by distinct genes (Verissimo and Jordan, 2001). Muta-
tions in WNK4 have also been found in patients with Gordon’s 
syndrome, but in contrast to WNK1, these comprise point muta-
tions lying within noncatalytic regions of this enzyme (Wilson 
et al., 2001). It is not yet clear how mutations in WNK4 lead to 
Gordon’s syndrome, but overexpression of a Gordon’s syn-
drome mutant of WNK4, but not the wild-type enzyme, 
increased blood pressure in mice (Lalioti et al., 2006).
Most functional studies on WNK isoforms have fo-
cused on the overexpression of these enzymes in Xenopus 
laevis oocytes or epithelial cells and monitoring the effects 
that this has on the activity and membrane localization of 
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utations within the WNK1 (with-no-K[Lys] 
  kinase-1) gene cause Gordon’s hypertension 
syndrome. Little is known about how WNK1 is 
regulated. We demonstrate that WNK1 is rapidly acti-
vated and phosphorylated at multiple residues after expo-
sure of cells to hyperosmotic conditions and that activation 
is mediated by the phosphorylation of its T-loop Ser382 
residue, possibly triggered by a transautophosphoryla-
tion reaction. Activation of WNK1 coincides with the 
phosphorylation and activation of two WNK1 substrates, 
namely, the protein kinases STE20/SPS1-related proline 
alanine–rich kinase (SPAK) and oxidative stress response 
kinase-1 (OSR1). Small interfering RNA depletion of 
WNK1 impairs SPAK/OSR1 activity and phosphoryla-
tion of residues targeted by WNK1. Hyperosmotic stress 
induces rapid redistribution of WNK1 from the cytosol to 
vesicular structures that may comprise trans-Golgi net-
work (TGN)/recycling endosomes, as they display rapid 
movement, colocalize with clathrin, adaptor protein com-
plex 1 (AP-1), and TGN46, but not the AP-2 plasma 
membrane–coated pit marker nor the endosomal markers 
EEA1, Hrs, and LAMP1. Mutational analysis suggests that 
the WNK1 C-terminal noncatalytic domain mediates 
vesicle localization. Our observations shed light on the 
mechanism by which WNK1 is regulated by hyperos-
motic stress.
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coexpressed ion cotransporters or ion channels. These have 
thus far revealed that WNK isoforms have effects on the activity 
and/or membrane expression of the thiazide-sensitive Na
+:Cl
− 
cotransporter (NCC), the bumetanide-sensitive Na
+:K
+:2Cl
− 
cotransporter-1/2 (NKCC1/2), the K
+:Cl
− cotransporter-2, the 
Cl
−:HCO3
− exchanger, the inwardly rectifying K
+ channel, 
the epithelial Na
+ channel, the tight junction claudin proteins, 
and the transient receptor potential vanilloid-4 Ca
2+ chan-
nel (for reviews see Delaloy et al., 2005; Kahle et al., 2005; 
Gamba, 2006).
Recent fi  ndings indicate that the protein kinases WNK1 
and -4 interact with high affi   nity with the protein kinases 
STE20/SPS1-related proline alanine–rich kinase (SPAK) and 
the oxidative stress response kinase-1 (OSR1; Piechotta et al., 
2003; Vitari et al., 2005; Gagnon et al., 2006). These observa-
tions were followed by the fi  nding that WNK1 and -4 could 
phosphorylate and activate SPAK and OSR1 in vitro (Moriguchi 
et al., 2005; Vitari et al., 2005; Anselmo et al., 2006). SPAK and 
OSR1 are phosphorylated by WNK1/WNK4 at a Thr residue 
located within the T-loop (Thr233-SPAK and Thr185-OSR1) as 
well as at a conserved noncatalytic Ser residue (Ser373-SPAK 
and Ser325-OSR1) lying within a region termed the S-motif 
(Vitari et al., 2005). Mutational analysis indicated that phos-
phorylation of the T-loop rather than the S-motif was required 
for the activation of SPAK and OSR1 by WNK1 (Vitari et al., 
2005). SPAK and OSR1 were originally identifi  ed  through 
their ability to interact, phosphorylate, and activate NKCC1 
(Piechotta et al., 2002; Dowd and Forbush, 2003) and may 
also regulate NCC (Pacheco-Alvarez et al., 2006). SPAK and 
OSR1 are 68% identical in sequence and possess a highly simi-
lar kinase catalytic domain as well as a conserved C-terminal 
(CCT) domain, which interacts with RFXV/I motifs present in 
both WNK isoforms as well as NKCC1 (Piechotta et al., 2002; 
Moriguchi et al., 2005; Gagnon et al., 2006; Vitari et al., 2006). 
The activity and phosphorylation of NKCC family cotransporters 
is stimulated by hyperosmotic stress (Lytle and Forbush, 1992; 
Kurihara et al., 1999; Darman and Forbush, 2002), conditions 
that have also been reported to enhance WNK1 activity (Xu 
et al., 2002; Lenertz et al., 2005) and induce phosphorylation 
of NKCC1 at the sites targeted by SPAK/OSR1 in vitro (Vitari 
et al., 2006). In this study, we investigate the mechanism by 
which WNK1 as well as its substrates SPAK/OSR1 are regulated 
by hyperosmotic stress.
Results
Activation of WNK1 
by hyperosmotic stress
It has been reported that hyperosmotic stress stimulates WNK1 
activity (Xu et al., 2002; Lenertz et al., 2005). As a prelude to 
investigating the mechanism by which WNK1 is regulated, 
we further assessed the activity of endogenous WNK1 in 293 
cells. We found that WNK1 immunoprecipitated from sorbitol-
treated cells phosphorylated OSR1 at an approximately three-
fold higher rate than WNK1 derived from nontreated cells 
(Fig. 1 A). Consistent with WNK1 mediating this phosphory-
lation, no phosphorylation of OSR1 was detected when a 
  mutated form of OSR1 in which the T-loop (Thr185) and S-motif 
(Ser325) sites phosphorylated by WNK1 were changed to Ala 
or when preimmune antibody was used instead of the specifi  c 
anti-WNK1 antibody in the immunoprecipitation step (Fig. 
1 A). A dose-dependent increase in WNK1 activity was observed 
by treatment with 0.1–1.0 M sorbitol, resulting in up to a fi  ve-
fold increase of WNK1 activity (Fig. 1 B). Activation of WNK1 
by 0.5 M sorbitol was detected within 0.5 min, with maximal 
activation being reached within 1–2 min, which was sustained 
for 80 min (Fig. 1 C). Consistent with hyperosmotic stress acti-
vating WNK1, treatment of cells with increasing concentrations 
of NaCl also induced activation of WNK1, which was detect-
able at 50 mM and maximal at 0.15 M (Fig. 1 D). Similarly, 
treatment of cells with 0.5 M KCl led to a threefold increase of 
WNK1 activity (Fig. 1 E). We next explored whether WNK1 
was activated by other stimuli, namely, serum, IGF-1, phorbol 
ester (TPA), oxidative stress (H2O2), hypotonic stress (medium 
diluted twofold in H2O), an NKCC1/2 inhibitor (bumetanide), 
TNFα, a tyrosine phosphatase inhibitor (pervanadate), or a serine/
threonine phosphatase inhibitor (calyculin A). These treatments 
failed to induce activation of WNK1 under conditions in which 
they triggered activation of other signaling pathways (Fig. 1 E). 
As 0.5 M sorbitol stimulated the extracellular signal–regulated 
kinase (ERK) 1/2, p38, and JNK protein kinases (Fig. 1 E), we 
investigated whether these enzymes might be involved in the 
activation of WNK1. Treatment of cells with the MEK inhibitor 
PD184352 (Fig. 1 F) or U0126 (not depicted) abolished ERK 
activation by sorbitol, without affecting WNK1 activation. The 
p38 inhibitor SB203580 and high concentrations of BIRB0796 
that inhibit all p38 and JNK isoforms (Kuma et al., 2005) also 
failed to prevent activation of WNK1 by sorbitol (Fig. 1 F). 
Consistent with p38 and JNK not regulating WNK1, aniso-
mycin that potently stimulates p38 and JNK failed to activate 
WNK1 (Fig. 1 F).
Hyperosmotic stress induces 
phosphorylation of WNK1 
at multiple residues
Despite the large size of WNK1 ( 250 kD), we consistently 
observed a reduction in the electrophoretic mobility of endog-
enous WNK1 isolated from sorbitol-treated cells on a poly-
acrylamide gel (Fig. 2 A). To assess whether this was due to 
enhanced phosphorylation, 293 cells were labeled with 
32P-
  orthophosphate and endogenous WNK1 was immunoprecipi-
tated from control and sorbitol-treated cells. Electrophoresis 
on a polyacrylamide gel revealed a Coomassie-stained band at 
 250 kD that was identifi  ed as WNK1 by mass spectrometry 
(Fig. 2 B). Autoradiographic analysis of the gel revealed that 
phosphorylation of WNK1 was stimulated by sorbitol (Fig. 
2 B). The 
32P-labeled WNK1 from control and sorbitol-treated 
cells was digested with trypsin, and the resulting peptides 
were chromatographed on a C18 column. Sorbitol substantially 
increased the abundance of several 
32P-labeled peptides (Fig. 
2 C). All phosphopeptides were subjected to mass spectros-
copy and some of them to solid phase Edman sequencing 
analysis, which enabled us to identify fi  ve sites of phosphory-
lation (Fig. 2 C). Phosphorylation of two sites, Ser1261 and REGULATION OF WNK1 AND SPAK/OSR1 KINASES • ZAGÓRSKA ET AL. 91
Ser 2372, was stimulated by treatment of cells with sorbitol, 
whereas Ser2012, Ser2029, and Ser2032 were phosphorylated 
at similar levels in WNK1 isolated from control and sorbitol-
stimulated cells.
As several of the phosphopeptides observed in the 
32P-cell–
labeling experiments presented in Fig. 2 B were not present 
at suffi  cient levels to enable phosphorylation site assignment, 
we undertook a mass spectrometry phosphopeptide mapping 
analysis of a larger amount of endogenous WNK1 immunopre-
cipitated from unlabeled control and sorbitol-treated 293 cells 
(Fig. 2 D). The immunoprecipitated WNK1 was digested with 
trypsin, and the resulting peptides were subjected to liquid chro-
matography/mass spectrometry with precursor ion scanning 
on a Q-TRAP mass spectrometer, which enabled us to assign 
fi  ve residues (Ser15, Ser167, Ser382, Ser1261, and Thr1848) 
whose phosphorylation was markedly enhanced by treatment 
of cells with sorbitol (Fig. 2 D). One of these sites, Ser382, 
which lies within the T-loop of the WNK1 catalytic domain, 
has been reported to be an autophosphorylation site on WNK1 
catalytic domain expressed in Escherichia coli (Xu et al., 2002). 
The location of all the phosphorylation sites identifi  ed within 
WNK1 and the amino acid sequences surrounding these sites 
are illustrated in Fig. 2 (E and F).
Phosphorylation mediates WNK1 activation 
induced by hyperosmotic stress
To verify whether the activity of WNK1 was infl  uenced by its 
phosphorylation state, we incubated WNK1 isolated from 
control and sorbitol-treated 293 cells with the serine/threonine 
protein phosphatase-1γ (PP1γ) and assessed its activity. We 
  observed that incubation with PP1γ substantially decreased 
both the basal and sorbitol-stimulated activity of WNK1 and 
also increased WNK1 electrophoretic mobility (Fig. 2 G). 
 Microcystin-LR, a toxin that specifi  cally inhibits serine/threonine 
phosphatases, prevented PP1γ-induced  inactivation as well as 
the increase in WNK1 electrophoretic mobility (Fig. 2 G).
Figure 1.  Characterization of WNK1 activity. (A) 293 cells were stimulated with 0.5 M sorbitol for 30 min. Immunoprecipitations from the cell lysates were 
performed with the anti-WNK1(CT) antibody (WNK1-Ab) or the preimmune antibody (PI-Ab), and the kinase activity of the immunoprecipitates was mea-
sured using either kinase-inactive OSR1[D164A] (ki-OSR1) or a mutant of OSR1 in which the WNK1 phosphorylation sites have been changed to Ala 
(ki-OSR1[T185A,S325A]). Phosphorylation of OSR1 was analyzed after electrophoresis on a polyacrylamide gel, Coomassie blue staining (middle), and 
autoradiography (top). The incorporation of phosphate was also quantiﬁ  ed on a Wallac Scintillation Counter (graph), and results are presented as the 
mean speciﬁ  c activity ± SD for duplicate samples. Similar results were obtained in at least two experiments. (B) As above, except that 293 cells were stimu-
lated with the indicated concentrations of sorbitol for 30 min. (C) As in A, except that 293 cells were stimulated with 0.5 M sorbitol for the indicated times. 
(D) As in B, except that 293 cells were stimulated with the indicated concentrations of NaCl for 30 min. (E) As in B, except that 293 cells were deprived 
of serum for 16 h and treated with the indicated stimuli for 30 min. For the hypotonic stimulation, the cell medium was diluted twofold in H2O. Cell lysates 
were also immunoblotted with the indicated antibodies. (F) As in E, except that cells were preincubated with 2 μM PD184352 for 30 min before stimulation 
with 0.5 M sorbitol for 30 min. (G) As in E, except that cells were either left untreated (−) or preincubated (+) with 10 μM SB203580 or the indicated con-
centrations of BIRB0796 for 30 min and then stimulated with 10 μg/ml anisomycin or 0.5 M sorbitol for an additional 30 min (in the continued absence 
or presence of inhibitor).JCB • VOLUME 176 • NUMBER 1 • 2007  92
Phosphorylation of Ser382 mediates 
activation of WNK1
We observed that an N-terminal fragment of WNK1 encompassing 
residues 1–667 retained the property of becoming activated after 
stimulation of 293 cells with sorbitol (Fig. 3). Mutation of Ser382 
that lies within the T-loop of WNK1 to Ala prevented activation of 
WNK1 by sorbitol treatment (Fig. 3 A), consistent with the previ-
ous report that this mutation inhibited WNK1 activity expressed in 
E. coli (Xu et al., 2002). Mutation of Ser382 to Glu enhanced the 
basal activity of WNK1[1–667] to a level that was over eightfold 
higher than that observed for wild-type WNK1[1–667] isolated 
from untreated cells (Fig. 3 A). The activity of the WNK1[S382E, 
1–667] mutant was not enhanced by sorbitol stimulation.
Sorbitol markedly increased recognition of WNK1[1–667] 
by a phospho-Ser382 antibody that we generated (Fig. 3 A). Con-
sistent with this antibody being specifi  c, mutation of Ser382 to 
Ala abolished its recognition of WNK1 (Fig. 3 A). We also ob-
served that sorbitol treatment induced Ser382 phosphorylation 
of a catalytically inactive WNK1[D368A, 1–667] mutant to the 
same extent as the catalytically active WNK1[1–667] fragment 
(Fig. 3 A), indicating that phosphorylation of WNK1 at Ser382 
was not mediated by intramolecular autophosphorylation.
WNK1 can autophosphorylate at Ser382
To determine whether WNK1 possesses the intrinsic   ability 
to autophosphorylate on Ser382, we expressed wild-type 
WNK1[1–661] or kinase-inactive WNK1[D368A, 1–661] in 
E. coli. Consistent with previous work (Xu et al., 2002), we ob-
served that the wild-type WNK1[1–661] was heavily phosphor-
ylated at Ser382 and also possessed a high specifi  c activity of 
5.2 U/mg (Fig. 3 B). The activity of E. coli expressed WNK1[1–
661] was much higher than that of the WNK1[1–667] fragment 
isolated from sorbitol-stimulated 293 cells, which had a spe-
cifi  c activity of only  0.13 U/mg (Fig. 3). We  observed that 
the kinase-inactive WNK1[D368A, 1–661]  mutant expressed 
in E. coli was not phosphorylated at Ser382 (Fig. 3 B). More-
over, the WNK1[S382A, 1–661], WNK1[S382E, 1–661], and 
WNK1[S382D, 1–661] mutants expressed in E. coli possessed 
low activities of 0.15, 0.66, and 0.26 U/mg, respectively (Fig. 3 B). 
Incubation of wild-type WNK1[1–661] with MgATP in vitro did 
not further increase phosphorylation of Ser382 (Fig. 3 C).
Figure 2. Identiﬁ  cation of phosphorylation sites on WNK1. (A) Endoge-
nous WNK1 was immunoprecipitated from control or sorbitol-stimulated 
(0.5 M for 30 min) 293 cells and subjected to immunoblot analysis with the 
anti-WNK1 antibody. (B) 293 cells were labeled with 
32P and left untreated 
or stimulated with 0.5 M sorbitol for 20 min. The endogenously expressed 
WNK1 was immunoprecipitated and subjected to electrophoresis on a 
polyacrylamide gel, which was then stained with colloidal Coomassie blue 
and autoradiographed. The Coomassie-stained bands migrating with the 
expected molecular mass of WNK1 were excised from the gel and di-
gested with trypsin, and a small aliquot (<1%) was analyzed by MALDI 
TOF/TOF mass spectrometry and conﬁ  rmed to contain WNK1 tryptic pep-
tides. (C) The remaining WNK1 tryptic peptides were chromatographed 
on a reverse-phase HPLC Vydac C18 column. The ﬁ  gure shows 
32P radio-
activity versus HPLC fraction number for the phosphopeptides derived from 
WNK1 isolated from control (blue) or sorbitol-stimulated (red) cells. A simi-
lar HPLC proﬁ  le was obtained in two separate experiments. All major 
32P-
labeled peptides were analyzed by MALDI TOF/TOF and 4000 Q-TRAP 
mass spectrometry. This resulted in the identiﬁ  cation of ﬁ  ve phosphopep-
tides indicated by the yellow boxes, and the sites of phosphorylation of the 
phosphopeptides identiﬁ  ed by MALDI TOF/TOF were conﬁ  rmed by solid-
phase Edman sequencing (Ed. seq.). There is mass spectrometry evidence 
that the peptide labeled with a solid square is a diphospho form of the D  V-
D  D  G  S  G  S  P  H  S  P  H  Q  L  S  S  K   peptide that may be labeled at both Ser2029 and 
Ser2032. (D) WNK1 was immunoprecipitated from 100 mg of unlabeled 
293 cell lysate derived from control or sorbitol-stimulated (0.5 M, for 30 
min) cells. The samples were subjected to electrophoresis on a polyacryl-
amide, and the Coomassie-stained bands corresponding to WNK1 were 
excised and digested with trypsin. Phosphopeptides were identiﬁ  ed  by 
combined liquid chromatography–mass spectrometry and tandem mass 
spectrometry analysis. The ﬁ  gure shows the signal intensity (cps, counts of 
ions per second detected) versus the ion distribution (m/z) for the phospho-
peptides derived from WNK1 isolated from control (blue) or sorbitol-stimu-
lated (red) cells. We were unable to identify the peptides marked with 
asterisks. (E) Illustration of the location of the identiﬁ  ed sorbitol-induced 
(red) and constitutive (blue) sites of phosphorylation within the WNK1 pro-
tein. KD, kinase domain (residues 221–479); CC, coiled-coil domains (res-
idues 189–221, 566–595, and 2072–2101). (F) The amino acid sequence 
surrounding each of the phosphorylation sites identiﬁ  ed in human WNK1 
is presented. The RFXV/I motif lying adjacent to the site of phosphorylation 
of Ser1261 is underlined. (G) WNK1 immunoprecipitates derived from 
control and sorbitol-stimulated (0.5 M, 30 min) 293 cells were incubated 
with PP1γ, in the presence or absence of microcystin-LR, an inhibitor of 
Ser/Thr protein phosphatases, and assayed as described in the legend to 
Fig. 1. The results are presented as relative activity compared with that of 
WNK1 isolated from untreated cells and not treated with PP1γ, which was 
given a value of 1.0. An aliquot of the reaction mixtures was also immuno-
blotted with the anti-WNK1 antibody. Similar results were obtained in two 
separate experiments conducted in duplicate.REGULATION OF WNK1 AND SPAK/OSR1 KINASES • ZAGÓRSKA ET AL. 93
Phosphorylation of Ser1261 may inhibit 
WNK1 interaction with SPAK/OSR1
As outlined in the introduction, WNK1 interacts with its sub-
strates SPAK and OSR1 through RFXV/I motifs. Interestingly, 
the site of phosphorylation, Ser1261, is located adjacent to 
such a motif (Fig. 2 E), suggesting that phosphorylation of 
Ser1261 might infl  uence the ability of WNK1 to bind SPAK 
and OSR1. To investigate this, we generated biotinylated pep-
tides that encompass residues surrounding Ser1261 in its phos-
phorylated or nonphosphorylated form. These were conjugated 
to streptavidin–Sepharose and tested for ability to affi  nity pu-
rify endogenously expressed SPAK and OSR1 from 293 cell 
extracts. The nonphosphorylated Ser1261 peptide interacted 
with SPAK and OSR1 to a markedly greater extent than the 
phosphorylated peptide (Fig. 4 A). Using a surface plasmon 
resonance binding assay, we also observed that the nonphos-
phorylated Ser1261 peptide interacted with a dissociation con-
stant of  40 nM with the isolated CCT domain of OSR1, 
whereas the phosphorylated Ser1261 peptide bound to OSR1 
with a markedly lower affi  nity (Fig. 4 B).
Hyperosmotic stress induces activation 
and phosphorylation of SPAK and OSR1
We next studied whether the downstream substrates of WNK1, 
SPAK and OSR1, were activated by hyperosmotic stress in 
HeLa and 293 cells. Endogenous SPAK and OSR1 were immuno-
precipitated from control and sorbitol-treated cells with an 
  antibody that immunoprecipitates both proteins and assayed us-
ing a peptide substrate termed CATCHtide (Vitari et al., 2006). 
The activity of SPAK/OSR1 was increased approximately fi  ve-
fold by sorbitol stimulation of HeLa cells (Fig. 5 A,  top) and 
approximately fourfold in 293 cells (Fig. S1, available at 
http://www.jcb.org/cgi/content/full/jcb.200605093/DC1). This 
is   consistent with previous reports that these enzymes are acti-
vated by sorbitol (Chen et al., 2004; Anselmo et al., 2006). We 
raised phosphospecifi  c antibodies that recognize the T-loop and 
S-motif residues on SPAK and OSR1 phosphorylated by 
WNK1. The sequences surrounding these sites are almost iden-
tical in SPAK and OSR1 (Vitari et al., 2005), suggesting that 
Figure 3.  Evidence that phosphorylation of Ser382 mediates WNK1 acti-
vation. (A) 293 cells were transfected with constructs encoding the indi-
cated forms of GST-WNK1[1–667]. 36 h after transfection, the cells were 
left untreated or treated with 0.5 M sorbitol for 30 min and lysed. GST-
WNK1 was afﬁ  nity puriﬁ  ed on glutathione–Sepharose and assayed as de-
scribed in the legend to Fig. 1. The results are presented as the mean 
relative activity ± SD compared with the activity observed for wild-type 
WNK1[1–667] isolated from untreated cells, which is given a value of 1.0 
(its speciﬁ  c activity was 0.13 U/mg). Similar results were obtained in at 
least two experiments conducted in duplicate. Cell lysates were immuno-
blotted with the indicated antibodies. (B) The indicated forms GST-
WNK1[1–661] were expressed in E. coli, puriﬁ  ed, and assayed. Results 
are presented as the mean speciﬁ  c activity for duplicate samples, and simi-
lar results were obtained in at least two experiments. An aliquot of the reac-
tion mixtures was also immunoblotted with the anti-WNK1 antibody. The 
WNK1[1–661], WNK1[S382E, 1–661], or WNK1[S382D, 1–661] frag-
ments migrate for unknown reasons as a doublet band on SDS-PAGE, 
whereas the WNK1[D368A, 1–661] or WNK1[S382A, 1–661] migrate 
as a single band with the expected molecular mass of 77 kD. The question 
mark indicates that the identity of the slower migrating WNK1 band is un-
certain. (C) The indicated forms of WNK1 puriﬁ  ed from E. coli were incu-
bated in the absence (−) or presence (+) of 0.1 mM ATP and 10 mM Mg 
for 1 h before immunoblotting with the indicated antibodies.
Figure 4.  Evidence that phosphorylation of Ser1261 inhibits binding of 
WNK1 to SPAK/OSR1. (A) The indicated amounts of a biotinylated peptide 
encompassing Ser1261 of WNK1 (biotin-A  G  R  R  F  I  V  S  P  V  P  E  S  R  L  ) or the phos-
phorylated form of this peptide (AGRRFIVpSPVPESRL) were conjugated to 
streptavidin–Sepharose and incubated with 1 mg of 293 cell lysate. After 
isolation and washes of the beads, the samples were electrophoresed on a 
polyacrylamide gel and immunoblotted with an antibody recognizing both 
SPAK and OSR1. (B) The binding of bacterially expressed puriﬁ  ed forms of 
the OSR1 CCT domain (residues 429–527) to the biotinylated peptides 
used above was analyzed using BiaCore. The analysis was performed 
over a range of protein concentrations (6.8–340 nM), and the response 
level at steady state was plotted against the log of the protein concentra-
tion. The dissociation constant was calculated by ﬁ  tting the data to the for-
mula (Y = Bmax*X/[Kd +X]) using GraphPad 4 software, which describes 
the binding of a ligand to a receptor that follows the law of mass action. 
Bmax is the maximal binding, and Kd is the concentration of ligand re-
quired to reach half-maximal binding. X and Y correspond to the protein 
concentration and the response units, respectively. The asterisk indicates 
that binding to the phosphorylated peptide was too weak to reliably calcu-
late a dissociation constant. JCB • VOLUME 176 • NUMBER 1 • 2007  94
the T-loop and S-motif phosphospecifi  c antibodies should rec-
ognize the phosphorylated forms of both SPAK and OSR1. The 
specifi  city of the antibodies was confi  rmed by overexpressing 
OSR1 (Fig. 5 B) or SPAK (Fig. 5 C) in 293 cells and fi  nding 
that mutation of the T-loop or S-motif residues to Ala abolished 
antibody recognition. Using these antibodies, we demonstrated 
that sorbitol treatment markedly stimulated the phosphoryla-
tion of endogenously expressed SPAK and OSR1 at both the 
T-loop and S-motif in HeLa cells (Fig. 5 A) as well as in 293 cells 
(Fig. S1). Sorbitol also induced a decrease in the electropho-
retic mobility of endogenous SPAK. Studying overexpressed 
OSR1 (Fig. 5 B) and SPAK (Fig. 5 C) in 293 cells, we observed 
that mutation of the T-loop, but not the S-motif, to Ala, inhib-
ited sorbitol-induced activation of these enzymes. We also 
found that mutation of the T-loop residue to Glu markedly in-
creased the basal activity of OSR1 and SPAK and the activity of 
these mutants was not further increased by sorbitol treatment of 
cells. Mutation of the S-motif to Glu moderately enhanced 
basal and sorbitol-stimulated OSR1 (Fig. 5 B) and SPAK (Fig. 
5 C) activity.
Evidence that WNK1 regulates SPAK and 
OSR1 activity and phosphorylation in vivo
We next investigated the effect of depleting the levels of endog-
enous WNK1 using a siRNA duplex targeting WNK1 that re-
duces expression >90% (Fig. 5 A). Under these conditions, 
sorbitol-induced phosphorylation of the T-loop and S-motif of 
SPAK and OSR1 were markedly reduced. Depletion of WNK1 
also inhibited the basal as well as sorbitol-induced SPAK/OSR1 
activity by >50% without affecting sorbitol-induced phosphor-
ylation of JNK isoforms at their T-loop residues (Fig. 5 A).
Hyperosmotic stress induces 
redistribution of WNK1 to intracellular 
vesicles colocalizing with clathrin
We also studied the localization of GFP-WNK1 (Fig. 6) that 
was stably expressed at a similar level to that of endogenous 
WNK1 (Vitari et al., 2004) as well as the localization of endog-
enous WNK1 in 293 cells (Fig. 7). In unstimulated cells, WNK1 
was diffusely localized throughout the cytosol (Figs. 6 and 7, 
panel 1), but after treatment with 0.2 M sorbitol for only 1 min, 
WNK1 was strikingly observed on discrete intracellular struc-
tures. Colocalization experiments revealed that both GFP- 
WNK1 and endogenous WNK1 colocalized with clathrin (Figs. 
6 and 7, panel 2) as well as AP-1 (Figs. 6 and 7, panel 3), which 
is an adaptor for clathrin and is recruited to budding vesicles at 
the TGN and endosomes (Hirst and Robinson, 1998). Partial 
colocalization between GFP-WNK1 and the TGN46 integral 
membrane protein that is predominantly localized to the TGN 
was also observed (Fig. 6, panel 4). In contrast, WNK1 did not 
colocalize with the early endosomal markers EEA1 (Mu et al., 
1995) and Hrs (Raiborg et al., 2001) or the late endosome and 
Figure 5.  Hyperosmotic stress leads to WNK1-mediated activation and phosphorylation of SPAK and OSR1. (A) HeLa cells were transfected with a control 
siRNA duplex or a siRNA duplex targeting human WNK1 as described in Materials and methods. 48 h after transfection, cells were either left untreated 
or stimulated with 0.5 M sorbitol for 30 min. Endogenously expressed SPAK and OSR1 were immunoprecipitated from the cell extracts using an antibody 
that immunoprecipitates both SPAK and OSR1, and their activity was assayed using the CATCHtide peptide substrate (Vitari et al., 2006). Results are pre-
sented as the mean relative activity ± SD compared with that observed for SPAK/OSR1 isolated from untreated cells that have been transfected with the 
control siRNA duplex, which was given a value of 1.0. Total cell extracts (20 μg) were also immunoblotted with the indicated antibodies. Similar results 
were obtained in three separate experiments conducted in duplicate. (B and C, top) 293 cells were transfected with constructs encoding the wild-type and 
indicated mutant forms of GST-OSR1 (B) or GST-SPAK (C). 36 h after transfection, the cells were left untreated or treated with 0.5 M sorbitol for 30 min and 
lysed. GST-OSR1/SPAK forms were afﬁ  nity puriﬁ  ed on glutathione–Sepharose and assayed using a fragment of NKCC1 encompassing residues 1–260. 
Results are presented as the mean relative activity ± SD compared with the activity observed for wild-type OSR1/SPAK isolated from untreated cells, which 
is given a value of 1.0. Similar results were obtained in at least two experiments conducted in triplicate. (bottom) The cell lysates were also immunoblotted 
with the indicated phosphospeciﬁ  c antibodies as well as anti-GST antibody to detect GST-OSR1/SPAK proteins.REGULATION OF WNK1 AND SPAK/OSR1 KINASES • ZAGÓRSKA ET AL. 95
lysosome marker LAMP1 (Rohrer et al., 1996; Figs. 6 and 7). 
Nor did it colocalize with the AP-2 adaptor (Figs. 6 and 7), 
which plays a central role in clathrin-mediated endocytosis by 
linking transmembrane receptors to be internalized to the clath-
rin lattice (Hirst and Robinson, 1998). We next investigated the re-
distribution of stably expressed GFP-WNK1 in living 293 cells 
using time-lapse microscopy (Fig. 8 and Videos 1 and 2, avail  able 
at http://www.jcb.org/cgi/content/full/jcb.200605093/DC1). 
The redistribution of GFP-WNK1 to intracellular vesicles after 
sorbitol (Video 1) or NaCl (Video 2) treatment was rapid 
and observed within  0.5 min, the earliest time point that 
we could monitor  (Fig. 8 A). Frames of the video were taken 
every 2 s, and substantial movement of some of the GFP-
WNK1 localized was observed within a 10–30-s time frame 
(Videos 1 and 2 and Figs. S2 and S3). This effect was revers-
ible, as removal of sorbitol or NaCl resulted in WNK1 becom-
ing diffusely localized in the cytosol within 2 min (Fig. 8 B). 
We also undertook an experiment of FRAP to monitor the 
  dynamics of WNK1 movement within the cells. In sorbitol- or 
NaCl-treated cells (Fig. 8 C), WNK1 became redistributed to 
the photobleached area within 2 min. This was slower than in 
untreated cells, where the recovery occurred within 0.5 min 
(unpublished data).
Figure 6.  Translocation of GFP-WNK1 to clathrin-coated vesicles after 
  hyperosmotic stress. 293 cells stably expressing GFP-WNK1 were left unstim-
ulated (control) or stimulated with 0.2 M sorbitol for 1 min, before ﬁ  xation. 
Cells were immunostained in the red channel with antibodies recognizing 
clathrin, AP-1, TGN46, EEA1, Hrs, LAMP1, or AP-2 and in the green chan-
nel for GFP-WNK1. Fluorescent imaging was performed on a confocal 
  microscope. Similar results were obtained in two independent experiments. 
Bar, 10 μm.
Figure 7.  Translocation of endogenous WNK1 to clathrin-coated vesicles 
after hyperosmotic stress. 293 cells were left unstimulated (control) or stim-
ulated with 0.2 M sorbitol for 1 min, before ﬁ  xation. Cells were immuno-
stained in the red channel with antibodies recognizing clathrin, AP-1, 
EEA1, Hrs, LAMP1, or AP-2 and in the green channel with the anti-WNK1 
antibody to detect endogenous WNK1. Fluorescent imaging was per-
formed on a confocal microscope. Similar results were obtained in two 
  independent experiments. Bar, 10 μm.JCB • VOLUME 176 • NUMBER 1 • 2007  96
The noncatalytic C-terminal domain 
of WNK1 mediates translocation 
to intracellular vesicles
We observed that the C-terminal noncatalytic domain of WNK1 
comprising residues 1504–2382 fused to GFP redistributed 
to intracellular vesicles after sorbitol stimulation, similar to 
full-length GFP-WNK1 (Fig. 9). In contrast, the N-terminal 
fragment (residues 1–667) comprising the catalytic domain 
  remained diffusely localized throughout the cytoplasm after 
sorbitol stimulation.
Discussion
Our fi  ndings are consistent with previous reports (Xu et al., 
2002; Lenertz et al., 2005) suggesting that endogenously ex-
pressed WNK1 is specifi  cally activated by hyperosmotic condi-
tions (sorbitol, NaCl, and KCl) and not by other stresses (H2O2, 
anisomycin, and phosphatase inhibitors), growth factors, cyto-
kines, phorbol esters, or the diuretic hypotensive agent bu-
metanide (Fig. 1). The activation of WNK1 by sorbitol is rapid 
and observed within 0.5 min, the earliest time point that we can 
practically investigate. Our data indicate that hyperosmotic 
stress activates WNK1 by stimulating its phosphorylation as in-
cubation of WNK1 with PP1γ lead to a decrease in its activity. 
Phosphopeptide mapping resulted in the identifi  cation of six 
residues on endogenous WNK1 whose phosphorylation is stim-
ulated with sorbitol (Fig. 2). Two of these sites are located 
N-terminal to the kinase domain (Ser15 and Ser167), one within 
the T-loop of the kinase domain (Ser382), and the other three 
sites are within the C-terminal noncatalytic region (Ser1261, 
Thr1848, and Ser2372). In addition, we have identifi  ed three 
other phosphorylation sites within the C-terminal region of 
WNK1 (Ser2012, Ser2029, and Ser2032) that are constitutively 
phosphorylated. We cannot rule out the possibility that there are 
additional phosphorylation sites on WNK1 that we have not 
been able to identify. Apart from Ser15, all the phosphorylation 
residues identifi  ed are conserved in mouse and rat WNK1. In 
Drosophila melanogaster WNK1, Ser382 and Ser2372 are con-
served, whereas in C. elegans WNK1, only Ser382 is conserved. 
The only phosphorylation site that is present in all human WNK 
isoforms is Ser382, and the residues surrounding this site are 
also identical in all WNK isoforms. Ser2372 is found in WNK2 
and -3, but not WNK4. Alignment of the sequences surrounding 
the WNK1 phosphorylation sites (Fig. 2 F) indicates that they 
are quite distinct, suggesting that different upstream kinases 
may be phosphorylating these residues in vivo. The only simi-
larity between three of the phosphorylation sites (Ser1261, 
Ser2029, and Ser2032) is that they possess a proline  residue 
following the site of phosphorylation. It would be interesting 
to investigate whether these residues were phosphorylated by 
a proline-directed kinase, such as an isoform of p38 or JNK. 
If this was the case, the phosphorylation of these sites may not 
be regulating WNK1 activity, as inhibitors of p38–JNK–ERK 
pathways did not prevent WNK1 activation (Fig. 1 F).
Our results suggest that phosphorylation of Ser382 is re-
quired for sorbitol-induced activation of WNK1, as mutation of 
Ser382 to Ala prevented WNK1 activation by sorbitol, whereas 
mutation of Ser382 to Glu to mimic phosphorylation increased 
activity of WNK1 and prevented further activation by sorbitol 
(Fig. 3). The conservation of Ser382 in all species of WNK iso-
forms is consistent with the notion that phosphorylation of this 
residue plays a crucial role in controlling the activity of WNK 
isoforms. It was previously reported that the isolated catalytic 
Figure 8.  Localization of GFP-WNK1 in living cells. (A) 293 cells stably 
expressing GFP-WNK1 were mounted in a heated chamber for live-cell 
  ﬂ  uorescent imaging using a confocal microscope. Images were collected 
  every 10 s. Before stimulation, cells were visualized for 2 min, and the cells 
labeled control correspond to a representative image of the cells during 
this period. After 2 min, the medium was exchanged with prewarmed me-
dium containing either 0.2 M sorbitol (top) or 0.2 M NaCl (bottom), and 
the cells were observed for a further 5 min. An image of the cells after 0.5 
and 2 min is shown. (B) As described in A, except that after imaging the 
sorbitol (top) or NaCl-treated (bottom) cells for 5 min, the medium was ex-
changed twice with prewarmed DME not containing sorbitol or NaCl and 
the cells were imaged for a further 5 min. The image of the cells after 1 and 
2 min is shown. (C) As in A, except that the region indicated with the dot-
ted circle was photobleached and cells were observed for a further 5 min, 
imaging every 10 s. The image of the cells after 2 min is shown. The pho-
tobleaching experiment was performed in duplicate, and at least four sep-
arate cells were visualized in each experiment. A representative cell from 
these experiments is shown. Bars, 10 μm.REGULATION OF WNK1 AND SPAK/OSR1 KINASES • ZAGÓRSKA ET AL. 97
domain of WNK1 encompassing residues 198–491, when ex-
pressed in E. coli, was phosphorylated at Ser378 and Ser382 
(Xu et al., 2002). This study showed that mutation of Ser382 to 
Ala inactivated the WNK1 enzyme, whereas mutation of Ser378 
to Ala only moderately reduced activity (Xu et al., 2002). In our 
peptide-mapping studies with endogenously expressed full-
length WNK1 we have not been able to detect phosphorylation 
of Ser378.
Our fi  ndings suggest that, in mammalian cells, phosphor-
ylation of Ser382 may be mediated by a transautophosphoryla-
tion reaction. This conclusion is based on the fi  nding  that 
wild-type WNK1, but not kinase-inactive WNK1, when ex-
pressed in E. coli, is phosphorylated at Ser382 (Fig. 3, B and C). 
In contrast, we observe that a catalytically inactive WNK1 mu-
tant is normally phosphorylated at Ser382 in response to sorbi-
tol when expressed in 293 cells (Fig. 3). These observations 
could be explained by the ability of endogenous WNK1 to 
transphosphorylate the kinase-inactive WNK1 mutant at Ser382 
(Fig. 3). However, our data do not rule out the possibility that 
there is another upstream kinase capable of phosphorylating 
Ser382 in response to hyperosmotic stress. Nor do our data rule 
out the possibility that hyperosmotic stress stimulates phos-
phorylation of Ser382 by inhibiting a protein phosphatase.
Further work is required to establish the roles of the novel 
sites of phosphorylation on WNK1 that we have identifi  ed. 
Apart from Ser382 (Fig. 3), we have also analyzed the effects 
that mutating other sorbitol-stimulated phosphorylation sites 
(Ser167, Ser1261, Thr1848, and Ser2372) had on regulating the 
activity of WNK1 expressed in 293 cells. We observed that in-
dividual mutation of these residues to either Ala or Glu did not 
markedly affect basal or sorbitol-stimulated WNK1 activity 
(unpublished data). We suggest that phosphorylation of Ser1261 
inhibits the interaction with the CCT domain of SPAK and 
OSR1 (Fig. 4). There are four RFXV/I motifs in the C-terminal 
region of WNK1, and a Ser or Thr residue follows all of these 
potential CCT binding sites. Interestingly, a Ser/Thr residue 
also follows several other RFXV/I motifs in other proposed 
SPAK/OSR1 binding proteins, including WNK4, NKCC2, and 
NCC. It is possible that phosphorylation of residues following 
RFXV/I motifs comprises a mechanism for dissociating WNK1 
from the CCT domains of SPAK and OSR1. We have attempted 
to detect dissociation of SPAK/OSR1 from WNK1 after sorbitol 
stimulation of cells but have not observed a marked decrease in 
the association between SPAK/OSR1 and WNK1. It is possible 
that nonstoichiometric phosphorylation of Ser1261 and/or the 
presence of other RFQV/I SPAK/OSR1 binding sites in WNK1 
masks detection of the dissociation of SPAK/OSR1 from WNK1 
in such an experiment.
We establish that hyperosmotic stress induces activation 
and phosphorylation of endogenous SPAK and OSR1 at their 
T-loop and S-motif, the sites phosphorylated by WNK1 in vitro 
(Fig. 5). Moreover, depletion of WNK1 by  90% using siRNA 
methodology markedly inhibited T-loop and S-motif phosphor-
ylation of SPAK/OSR1 and repressed basal and sorbitol-
  induced activation of these enzymes. Other isoforms of WNK 
or the remaining low level of WNK1 in these cells may medi-
ate the residual SPAK/OSR1 phosphorylation and activity. 
These data provide further evidence that SPAK/OSR1 are indeed 
regulated by WNK1 in vivo. While this study was under review, 
it was reported that siRNA knock down of WNK1 reduced 
OSR1 activity as well as its total phosphorylation in sorbitol-
treated cells, but the sites of phosphorylation affected by WNK1 
knockdown were not investigated in this study (Anselmo et al., 
2006). Our mutational analysis also confi  rms that phosphory-
lation of the T-loop of SPAK/OSR1 is required for sorbitol-
 induced activation of these enzymes (Fig. 5, B and C). Moreover, 
we fi  nd that individual mutation of the T-loop or S-motif 
does not affect phosphorylation of the other residue in sorbitol-
stimulated cells.
We observed that hyperosmotic stress (sorbitol and NaCl) 
induced a striking relocalization of WNK1 to intracellular vesi-
cles that are highly mobile (Videos 1 and 2) and colocalize with 
clathrin, AP-1, and partially with TGN46, but not with the en-
dosomal markers EEA1, Hrs, LAMP1, or AP-2, which colocal-
izes with plasma membrane–coated pits (Figs. 6 and 7). These 
results are consistent with the notion that after hyperosmotic 
stress, a considerable pool of WNK1 is localized to TGN/recy-
cling endosomes. We have not been able to demonstrate that en-
dogenous clathrin and WNK1 coimmunoprecipitate with each 
other from sorbitol-stimulated cells (unpublished data), indicat-
ing that these proteins may not interact directly. The traffi  cking 
Figure 9.  The C-terminal noncatalytic region of WNK1 mediates trans-
location to intracellular vesicles. 293 cells were transfected with the indi-
cated constructs encoding GFP-tagged WNK1. 24 h after transfection, the 
cells were left untreated or treated with 0.2 M sorbitol for 5 min and ana-
lyzed for cell ﬂ   uorescent imaging using a confocal microscope. Similar 
  results were obtained in two independent experiments. Bar, 10 μm.JCB • VOLUME 176 • NUMBER 1 • 2007  98
of several ion channels and cotransporters between intracellular 
vesicles and plasma membrane (see Introduction) is strongly 
infl  uenced by the overexpression of WNK isoforms. It is there-
fore possible that relocalization of WNK1 to TGN/recycling 
endosomes may enable it to regulate traffi  cking and/or activity 
of certain ion channels/cotransporters. Our fi  ndings based on 
the overexpression of fragments of WNK1 in 293 cells indicate 
that a C-terminal noncatalytic region of WNK1 mediates this 
relocalization (Fig. 9). Overexpression of catalytically inactive 
WNK1 or -4 decreased the membrane expression of the renal 
outer medullary potassium channel (ROMK) through a clathrin-
dependent endocytosis mechanism (Kahle et al., 2003; Cope 
et al., 2005). Overexpression of the C-terminal noncatalytic region 
of WNK3 decreased membrane expression of the potassium 
channel (Leng et al., 2006), and the C-terminal portion of 
WNK4 coimmunoprecipitated with ROMK in 293 cells (Kahle 
et al., 2003). Overall, these data suggest that the C-terminal por-
tion of the WNK isoforms plays an important role in infl  uencing 
WNK cellular localization and function.
In conclusion, our study defi  nes the striking effects that 
exposure of cells to hyperosmotic conditions has on WNK1 
phosphorylation, cellular localization, and catalytic activity as 
well as on its ability to interact with and activate its substrates 
SPAK and OSR1. In future studies, it would be important to de-
termine whether the capacity of hyperosmotic stress to stimu-
late WNK1 and SPAK/OSR1 plays a role in controlling cell 
volume and blood pressure. It will also be interesting to estab-
lish whether the reported effects that WNK isoforms have on 
ion channels and other cotransporters are mediated through ac-
tivation of SPAK/OSR1 and/or translocation of WNK1 to TGN/
recycling endosomes. It would also be essential to address 
whether WNK2, -3, and -4 isoforms are regulated in a manner 
similar to WNK1.
Materials and methods
Antibodies
The following antibodies were raised in sheep and afﬁ  nity puriﬁ  ed on the 
appropriate antigen: the SPAK/OSR1 (total) antibody was raised against 
the human full-length SPAK and OSR1 proteins, and the SPAK/OSR1
(T-loop) phospho-T233/T185 antibody was raised against a phosphopeptide 
encompassing residues 226–238 of human SPAK or residues 178–190 
of human OSR1 (TRNKVRKTpFVGTP). The SPAK/OSR1(S-motif) phospho-
S373/S325 was raised against a phosphopeptide encompassing residues 
367–379 of human SPAK (RRVPGSSpGHLHKT), which is highly similar to 
residues 319–331 of human OSR1 in which the sequence is RRVPGSSpGRL-
HKT. The antibody used for immunoblotting WNK1, termed WNK1(total), 
was raised in sheep against a fragment encompassing residues 61–661 
of human WNK1. The antibody used for immunoprecipitation of WNK1, 
termed WNK1(CT), was raised against a peptide encompassing residues 
2360–2382 of human WNK1 (Q  N  F  N  I  S  N  L  Q  K  S  I  S  N  P  P  G  S  N  L  R  T  T  ).
The PKB (total) antibody was raised in sheep against a peptide en-
compassing residues 466–480 of rat PKBα (R  P  M  F  P  Q  F  S  Y  S  A  S  G  T  A  ). The 
following antibodies were purchased from Cell Signaling: ERK1/2 (total), 
ERK1/2 phospho-Thr202/Tyr204, p38α (total), p38α phospho-Thr180/
Tyr182, and PKB phospho-Thr308. The JNK (total) and JNK phospho-
Thr183/Tyr185 antibodies were obtained from Biosource International. 
The mouse monoclonal antibody recognizing the GST tag was purchased 
from Roche. Secondary antibodies coupled to horseradish peroxidase 
used for immunoblotting were obtained from Pierce Chemical Co. For 
Li-COR analysis, the IRDye 800-conjugated anti-sheep antibody was pur-
chased from Rockland. Preimmune IgG used in control immunoprecipitation 
experiments were afﬁ  nity puriﬁ  ed from preimmune serum using protein G–
Sepharose. The clathrin antibody was purchased from Abcam, the EEA1 
and LAMP1 antibodies (raised in mouse) were purchased from BD Biosci-
ences, and the Hrs antibody was a gift from H. Stenmark (The Norwegian 
Radium Hospital, Oslo, Norway) and has been described previously 
(Raiborg et al., 2001). The AP-1 antibody (monoclonal anti–γ-adaptin AP6) 
was obtained from Sigma-Aldrich. The AP-2 antibody (monoclonal anti–α-
adaptin) was obtained from Afﬁ  nity BioReagents, Inc. The TGN46 anti-
body (polyclonal produced in sheep) was purchased from Serotec. Alexa 
Fluor 488 donkey anti–sheep, Alexa Fluor 595 donkey anti–rabbit, and 
Alexa Fluor 595 donkey anti–mouse secondary antibodies were obtained 
from Invitrogen.
Immunoprecipitation and assay of WNK1
Anti-WNK1(CT) and preimmune IgG antibodies were covalently coupled 
to protein G–Sepharose (1 μg of antibody per 1 μl of beads) using a di-
methyl pimelimidate cross-linking procedure. 0.5 mg of clariﬁ  ed cell lysate 
was incubated with 5 μg of anti-WNK1(CT) or preimmune IgG antibody 
conjugated to 5 μl of protein G–Sepharose and incubated for 1 h at 4°C 
with gentle agitation. The immunoprecipitates were washed twice with 
1 ml of lysis buffer containing 0.5 M NaCl and twice with 1 ml of buffer A. 
The in vitro phosphorylation reaction mix contained a ﬁ   nal volume of 
25 μl in buffer A containing 5 μM OSR1[D164A], 0.1 mM [γ
32P]ATP, and 
10 mM magnesium acetate. The assays were performed for 20 min at 30°C, 
and the reactions were terminated by adding SDS sample buffer. The sam-
ples were electrophoresed on a polyacrylamide gel, which was stained 
with Coomassie blue, dried, and autoradiographed. The OSR1 Coomassie 
bands were excised, and incorporation of 
32P-radioactivity was quantiﬁ  ed 
by Cerenkov counting. 1 U of activity was deﬁ  ned as the amount of WNK1 
that incorporated 1 nmol of 
32P into OSR1[D164A]. For experiments in Fig. 
3 A using overexpressed forms of GST-WNK1, WNK1 was afﬁ  nity puri-
ﬁ  ed from 0.1 mg of cell lysate using 5 μl of glutathione–Sepharose. The 
beads were washed, and assays were undertaken as described above.
Immunoprecipitation and assay of SPAK and OSR1
3 mg of clariﬁ  ed cell lysate was incubated with 5 μg of the SPAK/OSR1 
(total) antibody conjugated to 5 μl of protein G–Sepharose and incubated 
for 1 h at 4°C with gentle agitation. The immunoprecipitates were washed 
twice with 1 ml of lysis buffer containing 0.5 M NaCl and twice with 1 ml 
of buffer A. The SPAK/OSR1 immunoprecipitates were either assayed with 
the CATCHtide peptide substrate (R  R  H  Y  Y  Y  D  T  H  T  N  T  Y  Y  L  R  T  F  G  H  N  T  R  R  ) that 
encompasses the SPAK/OSR1 phosphorylation sites on NKCC1 (Vitari 
et al., 2006) or using the N-terminal fragment of NKCC1 encompassing 
residues 1–260 (NKCC1[1–260]; Vitari et al., 2005). Assays were set up in 
a total volume of either 50 μl (CATCHtide assay) or 25 μl (NKCC1 assay) 
in buffer A containing 10 mM MgCl2, 0.1 mM [γ
32P]ATP ( 300 cpm/
pmol) and 300 μM CATCHtide (R  R  H  Y  Y  Y  D  T  H  T  N  T  Y  Y  L  R  T  F  G  H  N  T  R  R  ), or 
5 μM NKCC1[1–260]. After incubation for 10–60 min at 30°C, the reaction 
mixture was applied onto P81 phosphocellulose paper (for the CATCHtide 
assay), the papers were washed in phosphoric acid, and incorporation of 
32P-radioactivity in CATCHtide was quantiﬁ  ed. For the NKCC1 assay, the 
reaction was stopped by the addition of SDS sample buffer. The samples 
were electrophoresed on a polyacrylamide gel, which was stained with 
Coomassie blue, dried, and autoradiographed. The NKCC1[1–260] Coo-
massie bands were excised, and incorporation of 
32P-radioactivity was 
quantiﬁ  ed by Cerenkov counting. For experiments in Fig. 5 (B and C) using 
overexpressed forms of GST-OSR1 and -SPAK, the GST fusion proteins 
were afﬁ  nity puriﬁ  ed from 0.5 mg of cell lysate using 5 μl of glutathione–
Sepharose. The beads were washed, and assays were undertaken as 
described above, using NKCC1[1–260] as a substrate.
Microscopy and image analysis
293 cells stably expressing GFP-WNK1 at levels similar to that of endoge-
nous WNK1 were described previously (Vitari et al., 2004). In experi-
ments in which the cells were ﬁ  xed before analysis, the cells were grown 
on coverslips (no. 1 1/2) and, after stimulation, were ﬁ  xed for 5 min in 
freshly prepared 3% vol/vol formaldehyde in PBS. The cells were washed 
twice in PBS (5 min each wash) and once in PBS containing 0.2% wt/vol 
Triton X-100, incubated 10 min in PBS-TG (PBS containing 0.2% wt/vol 
Tween +3% wt/vol of ﬁ  sh skin gelatine), and incubated for 1 h with anti-
clathrin/Hrs/AP-2/TGN46 antibodies (diluted 1:1,000 in PBS-TG), anti-
EEA1 antibody (diluted 1:100 in PBS-TG), anti-LAMP1 antibody (diluted 
1:50 in PBS-TG), or anti–AP-1 (diluted 1:2,500 in PBS-TG). Cells were 
washed three times in PBS-T (PBS containing 0.2% wt/vol Tween), incu-
bated for 30 min with the secondary antibody diluted 1:500 in PBS-TG, 
washed three times in PBS-T and once in water, and mounted onto slides 
using hydromount (National Diagnostics). Images were collected using the REGULATION OF WNK1 AND SPAK/OSR1 KINASES • ZAGÓRSKA ET AL. 99
α Plan 100× 1.45 NA Plan-Fluor objective on a confocal microscope 
(LSM 510 META; Carl Zeiss MicroImaging, Inc.). Fixed cells were imaged 
at room temperature ( 20°C) and live cells at 37°C. Images were ac-
quired using LSM 510 acquisition software (Carl Zeiss MicroImaging, 
Inc.), and no further processing of images was performed apart from as-
sembling montages in Photoshop/Illustrator (Adobe). Videos were edited 
in QuickTime Pro. For imaging of endogenous WNK1, untransfected 293 
cells were treated as described above except that 5 μg/ml of anti-
WNK1(Total) antibody was used. For live-cell imaging, 293 cells stably 
expressing GFP-WNK1 were grown on 35-mm-diameter glass-bottomed 
dishes (Willco). Cells were maintained at 37°C and 5% CO2 by the use of 
a microscopy incubator chamber (Carl Zeiss MicroImaging, Inc.). For 
each cell, optical sections of 0.5 μm were recorded at 2-s (for Videos 1 
and 2 and Figs. S2 and S3) or 10-s (Fig. 8) intervals. FRAP was performed 
using a bleached region of interest deﬁ  ned by the LSM 510 META soft-
ware. Recovery of ﬂ  uorescence was monitored by collecting images every 
second until recovery was complete. See the supplemental text (available 
at http://www.jcb.org/cgi/content/full/jcb.200605093/DC1) for fur-
ther methodological details.
Online supplemental material
The supplemental text contains additional methodological details on mate-
rials, buffers, and DNA constructs used, as well as protocols used for 
in vivo 
32P-labeling, identiﬁ  cation of phosphorylation sites by mass spectrom-
etry, immunoprecipitation, immunoblotting, and siRNA knockdown proto-
col. Fig. S1 shows that hyperosmotic stress leads to activation and 
phosphorylation of SPAK and OSR1 in 293 cells. Figs. S2 and S3 show 
selected time frames of videos of cells treated with sorbitol (Fig. S2 and 
Video 1) or NaCl (Fig. S3 and Video 2) to illustrate movement of vesicles 
to which GFP-WNK1 is recruited. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200605093/DC1.
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